These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9499818)

  • 21. [Functionality of inhalation aerosols is inadequate or lost at low temperature].
    Lundgren HW; Holmér I; Lidén G
    Lakartidningen; 2001 Mar; 98(13):1508-11. PubMed ID: 11330145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The best way to apply aerosol therapy. I--Methods].
    Battistini A
    Pediatr Med Chir; 1995; 17(2):97-103. PubMed ID: 7610089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of nebulization.
    Barry PW
    Respir Care; 2002 Dec; 47(12):1459-69; discussion 1469-70. PubMed ID: 12467503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization issues: in vitro assessment of nebulizer performance.
    Dennis JH
    Respir Care; 2002 Dec; 47(12):1445-55; discussion 1455-8. PubMed ID: 12467502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AARC (American Association for Respiratory Care) clinical practice guideline. Delivery of aerosols to the upper airway.
    Respir Care; 1994 Aug; 39(8):803-7. PubMed ID: 10146087
    [No Abstract]   [Full Text] [Related]  

  • 26. Aerosol delivery during mechanical ventilation.
    Hess D
    Minerva Anestesiol; 2002 May; 68(5):321-5. PubMed ID: 12029238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons between inhaled fine particle fractions and lung dose for nebulized aerosols.
    Finlay WH; Stapleton KW; Zuberbuhler P
    J Aerosol Med; 1998; 11 Suppl 1():S65-72. PubMed ID: 10180735
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-infective aerosols].
    Diot P; Dequin PF; Rivoire B; Gagnadoux F; Faurisson F; Diot E; Boissinot E; Lemarié E
    Rev Mal Respir; 1999 Jun; 16(3):277-85. PubMed ID: 10472633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and evaluation of a ribaviran aerosol administration system.
    Piepenbrink JC; Cullen JI; Chipman D
    Biomed Instrum Technol; 1991; 25(6):436-40. PubMed ID: 1777765
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro evaluation of aerosol delivery by different nebulization modes in pediatric and adult mechanical ventilators.
    Wan GH; Lin HL; Fink JB; Chen YH; Wang WJ; Chiu YC; Kao YY; Liu CJ
    Respir Care; 2014 Oct; 59(10):1494-500. PubMed ID: 24865422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is a respirable dose?
    Van Oort M; Truman K
    J Aerosol Med; 1998; 11 Suppl 1():S89-96. PubMed ID: 10180739
    [No Abstract]   [Full Text] [Related]  

  • 32. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.
    Borgström L; Asking L; Beckman O; Bondesson E; Källén A; Olsson B
    J Aerosol Med; 1998; 11 Suppl 1():S59-64. PubMed ID: 10180734
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current laboratory determination of "respirable mass" is not clinically relevant.
    Newhouse MT
    J Aerosol Med; 1998; 11 Suppl 1():S122-32. PubMed ID: 10180724
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug delivery to the lungs V. The Aerosol Society. December 15, 1994, London, UK. Abstracts.
    J Aerosol Med; 1995; 8(3):263-315. PubMed ID: 10184480
    [No Abstract]   [Full Text] [Related]  

  • 36. AARC (American Association of Respiratory Care) clinical practice guideline. Selection of an aerosal delivery device for neonatal and pediatric patients.
    Respir Care; 1995 Dec; 40(12):1325-35. PubMed ID: 10153259
    [No Abstract]   [Full Text] [Related]  

  • 37. Aerosol delivery devices.
    Crompton GK; Barnes PJ
    Chest; 2006 May; 129(5):1388-9; author reply 1389. PubMed ID: 16685035
    [No Abstract]   [Full Text] [Related]  

  • 38. [Better routines in connection with nebulizer therapy are required. New European guidelines serve as a guidance in Swedish health care, too].
    Lannefors L; Persson O; Löfdahl CG
    Lakartidningen; 2002 Oct; 99(42):4176-80. PubMed ID: 12448299
    [No Abstract]   [Full Text] [Related]  

  • 39. Respirable mass: vague and indefinable in disease.
    Smaldone GC; Diot P; Groth M; Ilowite J
    J Aerosol Med; 1998; 11 Suppl 1():S105-11. PubMed ID: 10180720
    [No Abstract]   [Full Text] [Related]  

  • 40. Liquid nebulization: emerging technologies conference summary.
    Hess DR
    Respir Care; 2002 Dec; 47(12):1471-6. PubMed ID: 12467504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.